Opens in a new tab

Dr. Zhong Weide

Chinese name: 钟惟德
Professor, Chief Physician, Doctoral Supervisor, Director of Urology . Urology
Dr. Zhong Weide is Director of Urology and Director of the Central Laboratory at Guangzhou First People's Hospital, and a Professor, Chief Physician and Doctoral Supervisor. A national talent of the New Century Hundred, Thousand and Ten Thousand Talents Project, he specialises in urological tumours and prostate cancer.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

100+
SCI-Indexed Papers
3
National Natural Science Foundation Projects
2009
Wu Jieping Urology Award

  • The Physician

About Dr. Zhong Weide

Dr. Zhong Weide is Director of Urology and Director of the Central Laboratory at Guangzhou First People's Hospital and Deputy Director of the Urological Oncology Pathology Laboratory at Massachusetts General Hospital, Harvard Medical School. A Professor, Chief Physician and Doctoral Supervisor, he is a national talent of the New Century Hundred, Thousand and Ten Thousand Talents Project and a recipient of the State Council Special Allowance. His research focuses on urological malignancies, prostate cancer and urinary stones. He has led more than ten national and provincial projects and published over two hundred papers, including fifty-five SCI-indexed articles.
1、Director of Urology and Director of the Central Laboratory at Guangzhou First People’s Hospital
2、Professor, Chief Physician and Doctoral Supervisor, and State Council Special Allowance expert
3、National talent of the New Century Hundred, Thousand and Ten Thousand Talents Project and first-tier talent of the Guangzhou 121 Talent Programme
4、Vice Chairman of the Youth Committee of the Urology Branch of the Chinese Medical Association and Chairman of the Guangzhou Medical Association
5、Academic adviser and visiting researcher at the University of Birmingham, Harvard Medical School and the Karolinska Institute
6、Holder of multiple national invention and utility patents and author of over two hundred papers

Dr. Zhong Weide ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Prostate and urological cancer

He diagnoses and treats prostate, kidney and bladder cancer, integrating minimally invasive surgery, molecular diagnosis and precision therapy to improve early detection, guide individualised treatment and extend long-term survival and quality of life for patients with these complex urological malignancies.

Urinary stones

He manages kidney, ureter and bladder stones using minimally invasive techniques such as percutaneous nephrolithotomy and ureteroscopy together with metabolic evaluation and prevention, relieving pain and obstruction, reducing recurrence and protecting kidney function in patients with complex or recurrent stones.

Prostate disease and benign prostatic hyperplasia

He treats benign prostatic hyperplasia, prostatitis and lower urinary tract symptoms, using medication and minimally invasive surgery to relieve obstruction, improve urinary flow, comfort and quality of life and prevent common complications for middle-aged and older men with prostate disease.

More： kidney cancer——minimally invasive surgery; bladder cancer——diagnosis and treatment; urinary tract infection——management; adrenal tumour——surgery; urological tumour——molecular research

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Molecular Profiling of Prostate Cancer
Prof. Zhong’s team developed inflammatory gene signatures to predict prostate cancer progression, published in Mathematical Biosciences and Engineering. Men with elevated PSA or suspected prostate cancer benefit from molecular evaluation guiding biopsy and treatment decisions, helping patients who search for a prostate cancer specialist in Guangzhou.
2. Targeting Therapy Resistance in Prostate Cancer
Research led by Prof. Zhong revealed how super-enhancers let prostate cancer escape metformin treatment, published in Signal Transduction and Targeted Therapy. This work guides new strategies for castration-resistant prostate cancer, helping patients with advanced prostate cancer who seek innovative treatment options.
3. Molecular Mechanisms of Bladder Cancer
Prof. Zhong’s group studied TFEB and related pathways in bladder cancer, offering insight into tumour growth and drug response. Patients with painless haematuria or suspected bladder cancer receive cystoscopy and molecular assessment, supporting early diagnosis for those searching for a urological tumour specialist in Guangzhou.
4. Minimally Invasive Treatment of Urinary Stones
Patients with kidney stones, ureteral stones or recurrent renal colic receive minimally invasive care including extracorporeal shock wave lithotripsy and ureteroscopy. Prof. Zhong’s department removes stones with less pain and faster recovery, helping patients with haematuria or back pain who need a stone specialist.
5. Comprehensive Care for Urological Malignancies
As leader of a national key clinical specialty in urology, Prof. Zhong treats kidney, bladder and prostate cancers. Patients receive multidisciplinary evaluation combining surgery, immunotherapy and targeted therapy, ensuring those with urological malignancies access advanced, evidence-based treatment at Guangzhou First People’s Hospital.
6. Robotic and Minimally Invasive Prostate Surgery
Men with localized prostate cancer can undergo minimally invasive or robot-assisted radical prostatectomy to preserve urinary and sexual function. Prof. Zhong’s team combines surgery with molecular risk assessment, guiding patients who seek a prostate operation or second opinion at a leading urology centre in Guangzhou.
  • Affiliated Hospital

Where Dr. Zhong Weide practices

Guangzhou

Guangzhou First People’s Hospital

Chinese name: 广州市第一人民医院
Guangzhou First People's Hospital, founded in 1899 and among Guangdong's first Grade-A tertiary hospitals, operates 2,970 licensed beds with 4,272 total staff and ranks in China's competitive top 100, with digestive, blood and spine specialties among its core strengths.
Since 1899
127 years of care
2,970
Licensed beds
2.94 million (2025)
Annual patient visits
SHARC certified
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zhong Weide?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zhong Weide.